In situ monitoring of carbamazepine–nicotinamide cocrystal intrinsic dissolution behaviour
Authors:
- Ke WangKWKe Wang
- Walkiria SchlindweinWalkiria Schlindwein
- Angela DaviesADAngela Davies
- Mingzhong LiMLMingzhong Li
- 1 April 2013
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 83 (3) , 415-426
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Monitoring lidocaine single‐crystal dissolution by ultraviolet imagingJournal of Pharmaceutical Sciences, 2011
- Solution-Mediated Phase Transformation of Salts During Dissolution: Investigation Using Haloperidol as a Model DrugJournal of Pharmaceutical Sciences, 2011
- Insights into the Early Dissolution Events of Amlodipine Using UV Imaging and Raman SpectroscopyMolecular Pharmaceutics, 2011
- Using Cocrystals To Systematically Modulate Aqueous Solubility and Melting Behavior of an Anticancer DrugJournal of the American Chemical Society, 2009
- Solvent-Mediated Solid Phase Transformations of cArbamazepine: Effects of Simulated Intestinal Fluid and Fasted State Simulated Intestinal FluidJournal of Pharmaceutical Sciences, 2009
- Applying Hot-Stage Microscopy to Co-Crystal Screening: A Study of Nicotinamide with Seven Active Pharmaceutical IngredientsCrystal Growth & Design, 2008
- Crystallization Pathways and Kinetics of Carbamazepine–Nicotinamide Cocrystals from the Amorphous State by In Situ Thermomicroscopy, Spectroscopy, and Calorimetry StudiesJournal of Pharmaceutical Sciences, 2007
- Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopyJournal of Pharmaceutical and Biomedical Analysis, 2006
- Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphsJournal of Pharmaceutical and Biomedical Analysis, 2004
- Combined approach of FTIR imaging and conventional dissolution tests applied to drug releaseJournal of Controlled Release, 2004